An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study

Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi, Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi

Abstract

Background: Accurate medication reconciliation reduces the risk of drug incompatibilities and adverse events that can occur during transitions in care. Community pharmacies (CPs) are a crucial part of the health care system and could be involved in collecting essential information on conventional and supplementary drugs used at home.

Objective: The aim of this paper was to establish an alliance between our cancer institute, Istituto Romagnolo per lo Studio dei Tumori (IRST), and CPs, the latter entrusted with the completion of a pharmacological recognition survey. We also aimed to integrate the national information technology (IT) platform of CPs with the electronic medical records of IRST.

Methods: Cancer patients undergoing antiblastic treatments were invited to select a CP taking part in the study and to complete the pharmacological recognition step. The information collected by the pharmacist was sent to the electronic medical records of IRST through the new IT platform, after which the oncologist performed the reconciliation process.

Results: A total of 66 CPs completed surveys for 134 patients. An average of 5.9 drugs per patient was used at home, with 12 or more used in the most advanced age groups. Moreover, 60% (80/134) of the patients used nonconventional products or critical foods. Some potential interactions between nonconventional medications and cancer treatments were reported.

Conclusions: In the PROF-1 (Progetto di Rete in Oncologia con le Farmacie di comunità della Romagna) study, an alliance was created between our cancer center and CPs to improve medication reconciliation, and a new integrated IT platform was validated.

Trial registration: ClinicalTrials.gov NCT04796142; https://ichgcp.net/clinical-trials-registry/NCT04796142.

Keywords: IT platform; community pharmacies; drug incompatibility; drug interactions; healthcare transitions; information technology; medication recognition; medication reconciliation; oncology; pharmacy.

Conflict of interest statement

Conflicts of Interest: None declared.

©Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 20.12.2021.

Figures

Figure 1
Figure 1
Dottorfarma electronic scheme of the recognition form.
Figure 2
Figure 2
Drug history section of the IRST (Istituto Romagnolo per lo Studio dei Tumori) electronic medical records.

References

    1. Raccomandazione n. 17. Riconciliazione della terapia farmacologica. Ministry of Health of Italy. 2014. Dec, [2021-12-09]. .
    1. Regione Emilia Romagna Sicurezza nella terapia farmacologica “Processo di ricognizione e di riconciliazione farmacologica per una prescrizione corretta e sicura”. Regione Emilia Romagna. 2015. Oct, [2021-12-09]. .
    1. Raccomandazione per la prevenzione degli errori in terapia con farmaci antineoplastici. Ministry of Health of Italy. 2012. Oct 14, [2021-11-09]. .
    1. No authors listed Using Medication Reconciliation to Prevent Errors. The Joint Commission Journal on Quality and Patient Safety. 2006 Apr;32(4):230–232. doi: 10.1016/s1553-7250(06)32030-2.S1553-7250(06)32030-2
    1. Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016 Apr;176(4):473–482. doi: 10.1001/jamainternmed.2015.8581. 2500064
    1. The High 5s Project. Interim Report. World Health Organisation. 2013. [2021-12-09]. .
    1. Kwan JL, Lo L, Sampson M, Shojania KG. Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013 Mar 05;158(5 Pt 2):397–403. doi: 10.7326/0003-4819-158-5-201303051-00006. 1656444
    1. The High 5s Project. Standard Operating Protocol. Assuring Medication Accuracy at Transitions in Care. World Health Organisation. [2021-12-09]. .
    1. Daruwalla Z, Thakkar V, Aggarwal M, Kiasatdolatabadi A, Guergachi A, Keshavjee K. Patient Empowerment: The Role of Technology. Stud Health Technol Inform. 2019;257:70–74.
    1. Gobal Oncology Trends 2019. The IQVIA Institute. [2021-12-09]. .
    1. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007 Apr 18;99(8):592–600. doi: 10.1093/jnci/djk130.99/8/592
    1. Alqenae FA, Steinke D, Keers RN. Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. Drug Saf. 2020 Jun;43(6):517–537. doi: 10.1007/s40264-020-00918-3. 10.1007/s40264-020-00918-3
    1. Bonaudo M, Martorana M, Dimonte V, D'Alfonso Alessandra, Fornero G, Politano G, Gianino MM. Medication discrepancies across multiple care transitions: A retrospective longitudinal cohort study in Italy. PLoS One. 2018;13(1):e0191028. doi: 10.1371/journal.pone.0191028. PONE-D-17-16149
    1. Medication Without Harm. World Health Organization. 2017. [2021-12-09]. .
    1. Monitoraggio della Spesa Farmaceutica Nazionale e Regionale Gennaio-Luglio 2020. Agenzia Italiana del Farmaco (AIFA) 2020. Dec 10, [2022-12-09]. .
    1. Rapporto Censis sul valore sociale dell’integratore alimentare. Centro Studi Investimenti Sociali (CENIS) 2019. [2021-12-09]. .
    1. Axelsson R, Axelsson SB. Integration and collaboration in public health--a conceptual framework. Int J Health Plann Manage. 2006;21(1):75–88. doi: 10.1002/hpm.826.
    1. Tenti E, Casadei Gardini A, Schirone A, Passardi A, Minguzzi M, Prati E, Amadori D. Medication reconciliation in cancer day hospital. JCO. 2015 May 20;33(15_suppl):e17748–e17748. doi: 10.1200/jco.2015.33.15_suppl.e17748.
    1. Mekonnen Alemayehu B, McLachlan Andrew J, Brien Jo-Anne E. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016 Feb 23;6(2):e010003. doi: 10.1136/bmjopen-2015-010003. bmjopen-2015-010003
    1. Mueller Stephanie K, Sponsler Kelly Cunningham, Kripalani Sunil, Schnipper Jeffrey L. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012 Jul 23;172(14):1057–69. doi: 10.1001/archinternmed.2012.2246. 1203516
    1. Broadfield Larry, Shaheen Philip, Rogez Michele, Jamieson Kara, McCallum Meg. Guidelines for outpatient cancer care by community pharmacists. Can Pharm J (Ott) 2017;150(1):24–31. doi: 10.1177/1715163516680009. 10.1177_1715163516680009
    1. Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012 Jul 23;172(14):1057–69. doi: 10.1001/archinternmed.2012.2246. 1203516
    1. Broadfield L, Shaheen P, Rogez M, Jamieson K, McCallum M. Guidelines for outpatient cancer care by community pharmacists. Can Pharm J (Ott) 2017;150(1):24–31. doi: 10.1177/1715163516680009. 10.1177_1715163516680009

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi